CWIAX
Price
$82.59
Change
+$0.54 (+0.66%)
Updated
Jun 2 closing price
Net Assets
151.89B
MWEGX
Price
$32.64
Change
-$0.13 (-0.40%)
Updated
Jun 2 closing price
Net Assets
1.5B
Interact to see
Advertisement

CWIAX vs MWEGX

Header iconCWIAX vs MWEGX Comparison
Open Charts CWIAX vs MWEGXBanner chart's image
CWIAX vs MWEGX Comparison Chart in %
View a ticker or compare two or three
VS
CWIAX vs. MWEGX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWIAX is a Buy and MWEGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWIAX has more cash in the bank: 152B vs. MWEGX (1.5B). CWIAX pays higher dividends than MWEGX: CWIAX (1.33) vs MWEGX (0.25). CWIAX was incepted earlier than MWEGX: CWIAX (24 years) vs MWEGX (21 years). MWEGX (1.97) is less costly to investors than CWIAX (0.75). CWIAX is a more actively managed with annual turnover of: 44.00 vs. MWEGX (17.00). MWEGX has a lower initial minimum investment than CWIAX: MWEGX (0) vs CWIAX (250). CWIAX annual gain was more profitable for investors over the last year : 22.44 vs. MWEGX (-14.23). CWIAX return over 5 years is better than : 38.19 vs. MWEGX (-37.30).
CWIAXMWEGXCWIAX / MWEGX
Total Expense Ratio0.751.9239%
Annual Report Gross Expense Ratio0.751.9738%
Fund Existence24 years21 years-
Gain YTD15.6520.7692,036%
Front Load4%N/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets152B1.5B10,160%
Annual Yield % from dividends1.330.25541%
Returns for 1 year22.44-14.23-158%
Returns for 3 years54.65-20.18-271%
Returns for 5 years38.19-37.30-102%
Returns for 10 years122.631.886,527%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSHAX12.600.20
+1.61%
NYLI Cushing® MLP Premier Class A
JCPRX25.76N/A
N/A
JPMorgan US Large Cap Core Plus R5
OIEIX26.19N/A
N/A
JPMorgan Equity Income A
RYBOX65.18N/A
N/A
Rydex Biotechnology A
PSKCX23.33N/A
N/A
Virtus KAR Mid-Cap Growth C